To study clinical and cardiovascular profile including TMT changes in tobacco addicts
Abstract
Introduction: Tobacco addiction remains a substantial problem in the worldwide. As a consequence of its addictive qualities, the consumption of tobacco often becomes a lifelong habit with cumulative and deleterious effects on health. The Treadmill test unmasks the occult disease and thereby influences the long term prognosis and treatment.
Material methods: A population based prospective observational study was performed in 200 subjects who agreed to participate in the evaluation and had a history of isolated tobacco-chewing and smoking were enrolled in study. The prevalence of major coronary risk factors- obesity, truncal obesity, hypertension, fasting hyperglycemia, and lipid levels were estimated using current guidelines. Electrocardiogram, Chest radiography and treadmill stress test was done in subjects when indicated by symptoms.
Results: Most of the subjects were in the age group of 41-50 years (87%), were male (96.5%). Maximum subjects were consuming tobacco for more than 20 years. Atypical chest pain was the most common associated symptom (48.5%). most of subjects were motivated by others either by peer groups or family members (25.5% and 22.5% respectively), Number of positive T.M.T. cases increases with age. In 41 to 50 year age group incidence of positive T.M.T. was more common (14.9%) and we found that the duration of addiction was more important than the quantity of tobacco.
Conclusion: Tobacco is the single greatest cause of preventable death globally, The effects depend on the number of years and how much a person smokes and chews. Tobacco addiction is highly prevalent in this part of country. The present work has been performed with the idea to detect the role of tobacco addiction in the development of the coronary artery disease. The treadmill test is presently the most simple, least expensive and fairly sensitive, non-invasive screening test for the early detection of latent ischemic heart disease.
Downloads
References
2. Taylor, A.E., Johnson, D.C., Kazemi, H Environmental tobacco smoke and cardiovascular disease: A position paper from the council on cardiopulmonary and critical care, American Heart Association Volume 86, Issue 2, 1992, Pages 699-702.
3. Salman Salahuddin tobacco and cardiovascular disease: challenges and opportunities Volume 7, Issue 2, July 2012, Pages 113–120.
4. P Niemiec et al. The CYBA gene A640G polymorphism influences predispositions to coronary artery disease through interactions with cigarette smoking and hypercholesterolemia Biomarkers, 16 (5), 405-412. 8 2011.
5 .Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation. 2005;112(4):489–97. [PubMed]
6. Blanco-Cedres L, Daviglus ML,et al. Relation of cigarette smoking to 25-year mortality in middle-aged men with low baseline serum cholesterol: the Chicago Heart Association Detection Project in Industry. American Journal of Epidemiology. 2002;155(4):354–60.
7. Prescott E, Scharling H, Osler M, Schnohr P. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality: a 22 year follow up of 12,149 men and women in the Copenhagen City Heart Study. Journal of Epidemiology and Community Health. 2002;56(9):702–6.
8. Bjartveit K, Tverdal A. Health consequences of smoking 1–4 cigarettes per day. Tobacco Control. 2005;14(5):315–20. [PubMed]
9. Law MR, Wald NJ. Environmental tobacco smoke and ischemic heart disease. Progress in Cardiovascular Diseases. 2003;46(1):31–8. [PubMed]
10.Whincup PH, Gilg JA, Emberson JR, Jarvis MJ, Feyerabend C, Bryant A, Walker M, Cook DG. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ (British Medical Journal) 2004;329(7459):200–5.
11. Thun MJ, Myers DG, Day-Lally C, Namboodin MM, Calle EE, Flanders WD, Adams SL, Heath CW Jr. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II, Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control. Smoking and Tobacco Control Monograph No 8. Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute; 1997. pp. 383–475. NIH Publication No. 97-4213.
12. Tverdal A. Calculation of risk for the development of acute myocardial infarction in the normal population based on long-term follow-up studies: smokers compared with non-smokers. Journal of Cardiovascular Risk. 1999;6(5):287–91.
13. Kuller LH, Ockene JK, Meilahn E, Wentworth DN, Svendsen KH, Neaton JD. Multiple Risk Factor Intervention Trial Research Group. Cigarette smoking and mortality. Preventive Medicine. 1991;20(5):638–54.
14. Ramakrishnan S Bhatt K, Acute electrocardiographic changes during smoking: an observational study BMJ Open 2013;3:e002486 doi:10.1136/bmjopen-2012 http://bmjopen.bmj.com
15. Asthana A, Megan E. Piper, Long-term effects of smoking and smoking cessation on exercise stress testing: Three-year outcomes from a randomized clinical trial Am Heart J. 2012 Jan; 163(1): 81–87.e1. https://www.ncbi.nlm.nih.gov
16. Gepner AD1, Piper ME Electrocardiographic changes associated with smoking and smoking cessation: outcomes from a randomized controlled trial. PLoS One. 2013 Apr 23;8(4):e62311. doi: 10.1371/journal.pone.0062311. Print 2013. https://www.ncbi.nlm.nih.gov
17. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction Cochrane Database Syst Rev. 2014; (12):CD010216. Epub 2014 Dec 17. https://www.ncbi.nlm.nih.gov
18. Victor U Ekpu1 and Abraham K Brown The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence Published online 2015 Jul 14. doi: 10.4137/TUI.S15628. [PubMed]
19. Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force [Internet]. 2015.
20. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Cochrane Database Syst Rev. 2015 Dec 22; (12):CD010078. Epub 2015 Dec 22.
21. Behera D1, Uppal R, Majumdar S. Urinary levels of nicotine & cotinine in tobacco users Indian J Med Res. 2003 Sep;118:129-33. [PubMed]
22. Matsumoto A, Matsumoto A, Ichiba M, Payton NM, Oishi H, Hara M. Simultaneous measurement of urinary total nicotine and cotinine as biomarkers of active and passive smoking among Japanese individuals. Environ Health Prev Med. 2013 May; 18(3):244-50. Epub 2012 Sep 26. [PubMed]
23. Pais P, Fay MP, Yusuf S. Increased risk of acute myocardial infarction associated with beedi and cigarette smoking in Indians: final report on tobacco risks from a case-control study. Indian Heart J 2001;53:731-5.
24. Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF, Smith S, Stone NJ, Taubert KA. American Heart Association guide for improving cardiovascular health at the community level. Circulation 2003;107:645-51.
25. Ezzati M1, Hoorn SV, Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet. 2003 Jul 26;362(9380):271-80.
26. Thomas KE1, Kisely S A Tale of Smoking Cessation Promotion. Clin Pediatr (Phila). 2016 Dec. [PubMed]
27. Berg ML1, Cheung KL Model-based economic evaluations in smoking cessation and their transferability to new contexts: A systematic review. Addiction. 2017 Jan 6.
OAI - Open Archives Initiative
